Vrundavan Chemicals is undertaking a significant expansion of its Active Pharmaceutical Ingredients (API) project at Panoli in Bharuch, Gujarat. The company has committed an investment of 8 crores towards this expansion, aiming to bolster its production capabilities. This strategic move is set to increase the monthly production capacity to an impressive 57.1 tons of APIs.
This expansion is a part of Vrundavan Chemicals' broader strategy to meet the growing demand for pharmaceutical ingredients both domestically and internationally. By scaling up production, the company aims to enhance its market presence and ensure a steady supply of high-quality APIs to its clients. The project aligns with the industry's growth trajectory and the increasing need for robust pharmaceutical infrastructure.
The Panoli facility, known for its state-of-the-art technology and adherence to stringent quality standards, will benefit from upgraded equipment and enhanced operational processes. These improvements are expected to optimize production efficiency and maintain the company's commitment to environmental sustainability and regulatory compliance.
The 8 crore investment underscores Vrundavan Chemicals' dedication to innovation and excellence in the pharmaceutical sector. The expansion not only promises economic benefits for the company but also contributes to the local economy by creating job opportunities and supporting ancillary industries.
News by Rahul Yelligetti